SMH
MRNA icon

Sanders Morris Harris’s Moderna MRNA Stock Holding History

Sanders Morris Harris’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,500
Closed -$297K – 298
2024
Q2 		$297K Sell
2,500
-175
-7% -$22.1K 0.05% 217
2024
Q1 		$285K Buy
+2,675
New +$270K 0.05% 214
2021
Q2 		– Sell
-6,000
Closed -$786K – 327
2021
Q1 		$786K Buy
+6,000
New +$869K 0.17% 106

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sanders Morris Harris's MRNA Position: Q3 2024 in Review

Sanders Morris Harris sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,500 shares — an estimated $297K sold.

Sanders Morris Harris first reported a position in MRNA in Q1 2021 and held it in 3 quarters. The position peaked at $786K in Q1 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Sanders Morris Harris reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Sanders Morris Harris sold 2,500 Moderna shares in Q3 2024, an estimated $297K.
  • Sanders Morris Harris first reported a position in Moderna in Q1 2021 and held it in 3 quarters.
  • Sanders Morris Harris's Moderna position peaked at $786K in Q1 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Sanders Morris Harris's 13F filing for Q3 2024, filed 9 Oct 2024.